Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/23/2025

Bicarbonate Administration in Hepatitis B-Related Chronic Liver Disease

Introduction to Bicarbonate Therapy

  • The American College of Physicians and other medical societies recommend that bicarbonate should NOT be given routinely to patients with hepatitis B-related chronic liver disease presenting with lactic acidosis, hyperkalemia, and metabolic acidosis, but may be considered only if arterial pH is ≤7.0-7.1 after ensuring adequate ventilation and treating the underlying cause 1, 2

Critical Decision Algorithm

  • The Kidney International guidelines suggest measuring arterial pH immediately to guide therapy, as venous pH may underestimate severity 3
  • If pH ≥7.15, the Kidney International guidelines recommend NOT giving bicarbonate 1, 3
  • If pH <7.0, the Praxis Medical Insights guidelines suggest considering bicarbonate cautiously after ensuring adequate ventilation 2

Management of Hyperkalemia

  • The Mayo Clinic Proceedings guidelines recommend that bicarbonate can help shift potassium intracellularly as a temporizing measure while definitive treatments are initiated, and suggest giving 1-2 mEq/kg IV slowly if using bicarbonate for hyperkalemia 3, 4
  • The Mayo Clinic Proceedings guidelines also recommend never using bicarbonate as monotherapy for hyperkalemia; combine with insulin/glucose, calcium gluconate, and consider dialysis 3, 4

Dosing Guidelines

  • The Praxis Medical Insights guidelines suggest an initial dose of 50 mmol (50 mL of 8.4% solution) given slowly IV, with a goal of pH 7.2, NOT complete normalization 2

Adverse Effects

  • The Kidney International guidelines warn that sodium and fluid overload worsen ascites and portal hypertension 1, 3
  • The Praxis Medical Insights guidelines also note that decreased ionized calcium impairs cardiac contractility in already compromised patients 3

Hemodialysis Considerations

  • The Mayo Clinic Proceedings guidelines recommend using bicarbonate-buffered dialysate, NOT lactate-buffered, for patients with liver disease 1, 4
  • The Mayo Clinic Proceedings guidelines also suggest that dialysis removes both lactate and potassium while correcting acidosis 3, 4

Evidence Quality Assessment

  • The Surviving Sepsis Campaign guidelines explicitly recommend against bicarbonate for pH ≥7.15, and the International consensus on CRRT specifically contraindicates lactate buffers in liver failure 1, 3

REFERENCES

2

Bicarbonate Therapy in Chronic Liver Disease [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Sodium Bicarbonate Infusion for Acidosis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

clinical management of hyperkalemia. [LINK]

Mayo Clinic Proceedings, 2021